Renovacor
BioTech/Drugs - N/A, N/A, US
Renovacor Employees
Jordan Shin
Senior Vice President, Clinical Development and Translational Science
Elizabeth White
Chief Business Officer & Senior Vice President of Operations
Renovacor Details
Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and related diseases. The company's lead program in BAG3-associated dilated cardiomyopathy (DCM) uses gene transfer technology to address the monogenic cause of this severe form of heart failure. Renovacor's vision is to bring life-changing therapies to patients living with serious genetic cardiovascular and related diseases, by developing medicines that target the underlying cause of disease and provide a transformative benefit and significant improvement to quality of life.
Renovacor Technologies
Email Providers
Outlook
Widgets
BugHerd
CMS
WordPress.org
Hosted Forms
Gravity Forms
Fonts
Typekit
Hosting
Flywheel